Pharmaceutical Market Cools

March 2007 | Industry Forecast

BMI has slightly downgraded its forecast for the Indonesian pharmaceutical market after official figures showed contraction in the last quarter of 2006, primarily as a result of decreasing public purchasing power and generic drug price cuts earlier in the year. According to the country's association of drugmakers - GP Farmasi - IDR24trn (US$2.6bn) was spent on medicines last year, which represented an 8.6% rise compared to 2005 (2004/05 growth equalled 12%). However, growth in Q406 was 3% down on the same period in the previous year, suggesting that the market is

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.